Taking shared decision making for prostate cancer to the next level: Requirements for a Dutch treatment decision aid with personalized risks on side effects.

Hochstenbach, Laura M J; Determann, Domino; Fijten, Rianne R R; Bloemen-van Gurp, Esther J; Verwey, Renée

Hochstenbach, Laura M J; Determann, Domino; Fijten, Rianne R R; Bloemen-van Gurp, Esther J; Verwey, Renée.

Afiliação

Hochstenbach LMJ; Center of Expertise for Innovative Care and Technology (EIZT), School of Nursing, Zuyd University of Applied Sciences, P.O. Box 550, 6400 AN Heerlen, the Netherlands.
Determann D; Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Faculty of Health Medicine and Life Sciences, Maastricht University, P.O. Box 616, 6200 MD Maastricht, the Netherlands.
Fijten RRR; PATIENT+, Zeestraat 76, 2518 AD Den Haag, the Netherlands.
Bloemen-van Gurp EJ; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, P.O. Box 616, 6200 MD Maastricht, the Netherlands.
Verwey R; Center of Expertise for Innovative Care and Technology (EIZT), School of Nursing, Zuyd University of Applied Sciences, P.O. Box 550, 6400 AN Heerlen, the Netherlands.

Internet Interv ; 31: 100606, 2023 Mar.

Article em En | MEDLINE | ID: mdl-36844795

Palavras-chave

Patient decision aid; Personalized medicine; Prostate cancer; Shared decision making; User centered design

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google